Symphony Ltd
SYMPHONYSymphony Ltd's price has outrun its earnings. −37.0% in a year against EPS −166.4% — the market is paying now for delivery later.
The sharpest disagreement: the price moved −37.0% in a year while annual EPS moved −166.4% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is in a downtrend (77 weeks in) while the P/E sits at the 100th percentile of its own 10-year range. Underneath, the last four quarters read deteriorating — profit −375.9% year on year, and 115% of the last 3 years' profit arrived as cash. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Symphony Ltd trades at ₹688, in a downtrend and 77 weeks into that stage. That is −15.4% against its own 200-day average. It sits at 6% of a 52-week range of ₹670 to ₹954. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (22 weeks and counting).
Today the stock is in a downtrend — week 77 of stage 4, confirmed. At ₹688 it trades −15.4% versus its 200-day average and sits at 6% of its 52-week range (₹670–₹954).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved −45% while the NIFTY 500 moved +276% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (22 weeks and counting; last ahead the week of 2026-03-20) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Symphony Ltd trades at 244.0× P/E, about the priciest it has ever traded. Its long-run median P/E is 55.5×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 244.0× is about the priciest it has ever traded, against a long-run median of 55.5× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
🚨 Why the multiple sits where it does: over the past year annual EPS moved −166.4% against a −37.0% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the −6.1%/yr price move, ~−29.9%/yr came from earnings growth and ~+23.8 pp from the multiple (expanding); over 10y, of the −5.4%/yr price move, ~−15.3%/yr came from earnings growth and ~+9.9 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
The PEG ratio and its quarterly curve, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 59% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Symphony Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −28.3% | −1.7% | +4.7% | +9.7% |
| Share price | −37.0% | −7.4% | −6.1% | −5.4% |
4-Factor Sector Score
33.6/100 — rank 11 of 13 in Consumer Electronics · 72% evidence confidence
Symphony Ltd scores 33.6 out of 100 against the 13 companies it is compared with in Consumer Electronics, ranking 11. Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression.
The four contributions add to the total exactly: 6.9 + 17.4 + 5.4 + 3.9 = 33.6. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Symphony Ltd reported ₹338 Cr of revenue in the Mar 26 quarter, −30.7% year on year. Over 10 years it has compounded at 9.7% a year. The last full year, FY26, came in at ₹1,130 Cr. The last four reported quarters add to ₹985 Cr.
FY26 revenue came in at ₹1,130 Cr (−28.3% on the year), capping 10 years at 9.7% compound. The latest quarter (Mar 26) printed ₹338 Cr, −30.7% year on year.
Pace check: the last four quarters averaged −28.5% growth against the decade's 9.7% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −30.2% over the last 4 quarters against −7.7%/yr over the last 8 — rolling over.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Symphony Ltd's operating margin is 15.0% in the Mar 26 quarter, −7.0 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 11.0% to 31.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 15.0%, −7.0 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 11.0%–31.0%.
🚨 Why the margin moved: operating margin went −7.1 pp year on year while gross margin went +0.1 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Symphony Ltd posted a net loss of ₹218 Cr in the Mar 26 quarter. The full FY26 year was a loss of ₹141 Cr. That loss is 64.5% of the quarter's revenue. The same quarter a year earlier earned ₹79.0 Cr. 2 of the last 12 reported quarters were loss-making.
Mar 26 profit was ₹−218 Cr, −375.9% year on year. On the full year, FY26 printed ₹−141 Cr (−166.5%).
🚨 Why profit moved: revenue contributed −30.7% and the margin −7.0 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −164.8% vs revenue −28.5%. Profit is growing slower than sales — costs are eating the growth before it reaches the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 115% of Symphony Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹−81.0 Cr of operating cash against ₹−141 Cr of profit. After ₹−131 Cr of capital spending, ₹50.0 Cr was left as free cash.
FY26: operating cash of ₹−81.0 Cr against reported profit of ₹−141 Cr, leaving free cash of ₹50.0 Cr after ₹−131 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 115% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 115%: the cash cycle stretched 107 days between FY21 and FY26 — more of each rupee of profit waits inside the cycle before arriving.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Symphony Ltd's cash conversion cycle runs 162 days in FY26, up from 55 days in FY21. Capital spending ran ₹−112 Cr over the last 3 years. At FY26 sales of ₹1,130 Cr each day of that cycle holds about ₹3.1 Cr, so roughly ₹502 Cr sits inside the business at any moment.
FY26: debtors at 49 days, inventory at 193 days — roughly 6.3 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 162 days, looser than FY21's 55.
The full loop: cash goes out to suppliers and production on day 0; stock waits 193 days to sell; customers pay about 49 days after that; and suppliers themselves are paid at 79 days — netting out to the 162-day cycle.
In money terms: at FY26 sales of ₹1,130 Cr, each day of the cycle holds about ₹3.1 Cr — so the 162-day loop keeps roughly ₹502 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹−112 Cr over the last 3 fiscal years against ₹68.0 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹0.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.
Symphony Ltd earns a ROCE of 21% in FY26. That is up from a trough of 15% in FY23. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is −12.5% net margin on 1.10× asset turns.
FY26 ROCE is 21%, recovered from a FY23 trough of 15% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY26): −12.5% net margin × 1.10× asset turns × 1.89× balance-sheet leverage ≈ −26.0% on equity. Margin does its share; leverage is a meaningful part of the equation.
The quarterly return curves and the return-on-invested-capital overlay, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 59% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Symphony Ltd carries ₹173 Cr of borrowings against ₹545 Cr of equity in FY26, a debt-to-equity of 0.32. Operating profit covers the interest bill 7×. Over 5 years borrowings went from ₹219 Cr to ₹173 Cr. Capital spending ran ₹−112 Cr across the last 3 of those years.
FY26: borrowings of ₹173 Cr against equity of ₹545 Cr — a debt-to-equity of 0.32. Operating profit covers the interest bill 7×. Over 5 years borrowings went from ₹219 Cr to ₹173 Cr while capital spending ran ₹−112 Cr in just the last 3 — the build-out is being paid for out of cash, not debt.
The total-debt and debt-to-equity series, which only the second data source carries, are not drawn on this page: its two data sources disagree by up to 59% on reported income across 14 comparable periods. A figure two sources cannot agree on is not drawn — the gap is a decision, not missing data.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Foreign institutions cut 2.4 points of Symphony Ltd over 8 quarters, the biggest move on the register. That takes foreign institutions to 2.4% of the company. Domestic institutions moved −1.5 points over the same window, to 8.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Foreign institutions: −2.4 points over 8 quarters to 2.4%; Domestic institutions: −1.5 points over 8 quarters to 8.5%; Promoters: +0.0 points over 8 quarters to 73.4%.
🚨 Why the register moved: foreign institutions drove it (−2.4 points), alongside domestic institutions (−1.5 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Symphony Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Orient Electric LtdORIENTELEC | 73.4/100Favorable setup100% evidence | ASLEEP | 31.0/35 Revenue 12.8% · PAT 26.7% · OPM change 1 pp 100% evidence | 13.9/25 ROCE 19.9% · OPM 7% 100% evidence | 19.4/20 P/E 31.3× · PEG 0.83 100% evidence | 9.1/20 RS sector -4.1% · RS bench -7.4% · 1Y -21.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 31 + 13.9 + 19.4 + 9.1 = 73.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Eureka Forbes LtdEUREKAFORB | 57.0/100Mixed-positive evidence90% evidence | ASLEEP | 22.5/35 Revenue 11.2% · PAT -0.6% · OPM change 0 pp 88% evidence | 11.3/25 ROCE 5.9% · OPM 13% 100% evidence | 16.4/20 P/E 45× · PEG 1.26 100% evidence | 6.8/20 RS sector -4.2% · RS bench -15.9% · 1Y -19.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 22.5 + 11.3 + 16.4 + 6.8 = 57 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Havells India LtdHAVELLS | 56.3/100Mixed-positive evidence100% evidence | TURNING | 23.3/35 Revenue 10.1% · PAT 15.6% · OPM change -2 pp 100% evidence | 16.9/25 ROCE 24.9% · OPM 7% 100% evidence | 7.2/20 P/E 47.5× · PEG 3.13 100% evidence | 8.9/20 RS sector -5.4% · RS bench -8.7% · 1Y -17.3%0 of 12 weeks ahead 100% evidence |
| Exact sum: 23.3 + 16.9 + 7.2 + 8.9 = 56.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Blue Star LtdBLUESTARCO | 54.8/100Mixed-positive evidence86% evidence | ASLEEP | 20.4/35 Revenue 3.6% · PAT -10.7% · OPM change 1 pp 88% evidence | 18.0/25 ROCE 21.2% · OPM 8% 100% evidence | 9.5/20 P/E 61.9× · PEG — 50% evidence | 6.9/20 RS sector -4.1% · RS bench -7.3% · 1Y -3.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 18 + 9.5 + 6.9 = 54.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Crompton Greaves Consumer Electricals LtdCROMPTON | 51.3/100Mixed-positive evidence78% evidence | ASLEEP | 15.5/35 Revenue 2.9% · PAT -80% · OPM change -1 pp 83% evidence | 15.2/25 ROCE 18.1% · OPM 12% 76% evidence | 8.9/20 P/E 50× · PEG — 50% evidence | 11.7/20 RS sector -2.2% · RS bench -5.6% · 1Y -20.9%6 of 12 weeks ahead 100% evidence |
| Exact sum: 15.5 + 15.2 + 8.9 + 11.7 = 51.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6LG Electronics India LtdLGEINDIA | 50.4/100Mixed-positive evidence69% evidence | ASLEEP | 12.6/35 Revenue 1% · PAT -23.6% · OPM change -2 pp 88% evidence | 21.3/25 ROCE 32.2% · OPM 12% 100% evidence | 6.5/20 P/E 60× · PEG 2.76 65% evidence | 10.0/20 RS sector — · RS bench — · 1Y —2 of 12 weeks ahead 0% evidence |
| Exact sum: 12.6 + 21.3 + 6.5 + 10 = 50.4 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 7Whirlpool of India LtdWHIRLPOOL | 41.4/100Mixed-negative evidence90% evidence | ASLEEP | 15.2/35 Revenue 1.4% · PAT -18.7% · OPM change -3 pp 88% evidence | 11.3/25 ROCE 11.1% · OPM 6% 100% evidence | 11.9/20 P/E 32.4× · PEG 2.31 100% evidence | 3.0/20 RS sector -17.6% · RS bench -20.3% · 1Y -42.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 15.2 + 11.3 + 11.9 + 3 = 41.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Wonder Electricals LtdWEL | 39.2/100Mixed-negative evidence70% evidence | TURNING | 13.2/35 Revenue -26.8% · PAT -52% · OPM change -0.1 pp 83% evidence | 11.8/25 ROCE 9.4% · OPM 5.5% 95% evidence | 9.1/20 P/E 176× · PEG — 15% evidence | 5.1/20 RS sector -10.1% · RS bench -9.8% · 1Y -29.3%2 of 10 weeks ahead 70% evidence |
| Exact sum: 13.2 + 11.8 + 9.1 + 5.1 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9MIRC Electronics LtdMIRCELECTR | 37.0/100Mixed-negative evidence68% evidence | 5.0/35 Revenue -11.7% · PAT -80% · OPM change -11 pp 83% evidence | 3.4/25 ROCE -16.4% · OPM -11% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 18.6/20 RS sector 38% · RS bench 33.7% · 1Y 126.7%6 of 6 weeks ahead to 2026-06-21 100% evidence | |
| Exact sum: 5 + 3.4 + 10 + 18.6 = 37 · Decision use: Price leads the evidence: RS versus the benchmark is 33.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 10Voltas LtdVOLTAS | 35.9/100Mixed-negative evidence78% evidence | ASLEEP | 11.3/35 Revenue -7.6% · PAT -55.7% · OPM change -2.2 pp 83% evidence | 8.1/25 ROCE 9% · OPM 3.8% 76% evidence | 7.3/20 P/E 112× · PEG — 50% evidence | 9.2/20 RS sector -1.2% · RS bench -4.4% · 1Y 1%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.3 + 8.1 + 7.3 + 9.2 = 35.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Symphony Ltdthis pageSYMPHONY | 33.6/100Adverse evidence72% evidence | ASLEEP | 6.9/35 Revenue -30.2% · PAT -80% · OPM change -7 pp 83% evidence | 17.4/25 ROCE 20.6% · OPM 15% 76% evidence | 5.4/20 P/E 244× · PEG — 50% evidence | 3.9/20 RS sector -15.2% · RS bench -18.3% · 1Y -38.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 6.9 + 17.4 + 5.4 + 3.9 = 33.6 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 12Bosch Home Comfort India LtdBOSCH-HCIL | 30.0/100Adverse evidence78% evidence | ASLEEP | 9.0/35 Revenue -2.1% · PAT -80% · OPM change -3 pp 83% evidence | 6.0/25 ROCE 4.6% · OPM 7% 76% evidence | 5.6/20 P/E 291× · PEG — 50% evidence | 9.4/20 RS sector -4.2% · RS bench -7.6% · 1Y -20%2 of 12 weeks ahead 100% evidence |
| Exact sum: 9 + 6 + 5.6 + 9.4 = 30 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Onida Electronics LtdONIDA | 28.5/100Thin evidence · provisional58% evidence | 5.0/35 Revenue -11.7% · PAT -80% · OPM change -10.8 pp 83% evidence | 1.3/25 ROCE -16.4% · OPM -11% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.2/20 RS sector — · RS bench 25.2% · 1Y — 25% evidence | |
| Exact sum: 5 + 1.3 + 10 + 12.2 = 28.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Symphony Ltd's share price today?
Symphony Ltd trades at ₹688, −37.0% over the past year. The company is valued at ₹4,726 Cr. The stock sits at 6% of its 52-week range of ₹670–₹954, −15.4% versus its 200-day average. On the tape, the price is in a downtrend, 77 weeks in. — as of 31 July 2026.
What were Symphony Ltd's latest quarterly results?
Symphony Ltd reported revenue of ₹338 Cr and a net loss of ₹218 Cr for the Mar 26 quarter. Revenue fell 30.7% and profit fell 375.9% year on year. Earnings per share were ₹−31.75. The operating margin was 15.0%, 7.0 pp lower than a year earlier. — as of 31 July 2026.
What is Symphony Ltd's revenue?
Symphony Ltd reported revenue of ₹338 Cr in the Mar 26 quarter, −30.7% year on year. For the full FY26 fiscal year, revenue was ₹1,130 Cr (−28.3%). Over the last 10 years revenue compounded at 9.7% a year. — as of 31 July 2026.
What is Symphony Ltd's profit?
Symphony Ltd earned ₹−218 Cr of net profit in the Mar 26 quarter, −375.9% year on year. Full-year FY26 profit was ₹−141 Cr. The operating margin ran 15.0% in the latest quarter. — as of 31 July 2026.
What is Symphony Ltd's market cap?
Symphony Ltd's market capitalisation is ₹4,726 Cr at a share price of ₹688. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Symphony Ltd's P/E ratio?
Symphony Ltd trades at a P/E of 244.0×, at the 100th percentile of its own 10-year range, against a long-run median of 55.5×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Symphony Ltd pay a dividend?
Not in its latest year — Symphony Ltd's dividend payout was 0% of profit in FY26. It did record a payout in 12 of its last 13 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Symphony Ltd overvalued?
On its own history, Symphony Ltd looks expensive against its own history: its P/E of 244.0× sits at the 100th percentile of its 10-year range (long-run median 55.5×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Symphony Ltd growing?
Not right now — Symphony Ltd's latest numbers are shrinking: latest-quarter revenue −30.7% year on year, profit −375.9%, and the margin −7.0 pp at 15.0%. The earnings engine currently reads: deteriorating — as of 31 July 2026.
How is Symphony Ltd performing?
Symphony Ltd is in a downtrend, 77 weeks in. Its latest quarter's revenue fell 30.7% and profit fell 375.9% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 22 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
Is Symphony Ltd in an uptrend?
No — the price is in a downtrend (week 77 of stage 4), trading −15.4% versus its 200-day average and at 6% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Symphony Ltd beating the market?
Not lately — on a trailing-13-week view Symphony Ltd is currently behind the NIFTY 500 (22 weeks and counting; last ahead the week of 2026-03-20), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved −45% against the NIFTY 500's +276% — behind the index over the full window. — as of 31 July 2026.
Will Symphony Ltd's share price go up?
This page publishes no price forecast for Symphony Ltd. What it measures instead: the share price is ₹688, the price is in a downtrend 77 weeks in. Its P/E of 244.0× sits at the 100th percentile of its own 10-year range. Direction is not something this site claims to know. — as of 31 July 2026.
Who owns Symphony Ltd?
Promoters hold 73.4% of Symphony Ltd, foreign institutions 2.4%, domestic institutions 8.5% and the public 15.7% (latest quarter). The biggest move on the register over the last two years: Foreign institutions cut 2.4 points over 8 quarters. — as of 31 July 2026.
Does Symphony Ltd have too much debt?
It is moderate — Symphony Ltd's debt-to-equity is 0.32, and operating profit covers the interest bill 7×. FY26 borrowings were ₹173 Cr against equity of ₹545 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Symphony Ltd's capex?
Symphony Ltd spent ₹−112 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹−131 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Symphony Ltd's cash flow?
Symphony Ltd generated ₹−81.0 Cr of operating cash flow in FY26 and ₹50.0 Cr of free cash flow after ₹−131 Cr of capital spending. Reported profit that year was ₹−141 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Symphony Ltd's profit real cash?
Yes — over the last 3 fiscal years, 115% of Symphony Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹−81.0 Cr against reported profit of ₹−141 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Symphony Ltd in its business cycle?
Symphony Ltd's FY26 operating margin was 11.0%, against a 13-year band of 11.0%–31.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 15.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Symphony Ltd story?
The sharpest disagreement: the price moved −37.0% in a year while annual EPS moved −166.4% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Symphony Ltd a stock worth studying right now?
This is not investment advice. The machine read: Symphony Ltd's price has outrun its earnings. −37.0% in a year against EPS −166.4% — the market is paying now for delivery later. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.